How does Helical plc generate revenue?

Helical plc generates revenue from rental income and capital appreciation.

Helical — TickStock

Timeline

Helical inks letting deal of Old Street property

08:11, 10 Jun 2026

Helical advances lettings and de‑risks pipeline ahead of full‑year results

12:30, 22 Apr 2026

More in Pharma

A laboratory technician is performing an analysis in a lab setting, wearing protective gear and using pipettes. The workspace features various laboratory equipment and samples, emphasizing a research environment.

Pharma

Hansoh Phase III win bolsters GSK's global case for Ris-Rez in lung cancer

Positive overall survival data from a China trial of risvutatug rezetecan marks the first Phase III success for any B7-H3-targeted antibody-drug conjugate, strengthening GSK's broader development programme.

Updated 14:01, 10 Jul 2026

Biotech

Health & Bio Today: AstraZeneca ATTR-CM trial fails primary endpoint, Avacta, Spire Healthcare, Smith+Nephew

17:02, 9 Jul 2026

Pharma

AstraZeneca and Ionis ATTR-CM trial fails primary endpoint

07:36, 9 Jul 2026

Pharma

OKYO Pharma accelerates urcosimod into Phase 3 after FDA validates trial design

13:39, 8 Jul 2026

Biotech

Physiomics wins contracts across two service lines

10:21, 8 Jul 2026

Real Estate & REITs

Segro doubles new rent secured in first half as development pipeline hits record

09:55, 8 Jul 2026

Biotech

Coiled Therapeutics advances softgel formulation ahead of dose expansion

10:42, 7 Jul 2026

Medtech & Diagnostics

MedPal AI raises £5m to acquire care-home software firm and launch oral Wegovy clinic

07:53, 3 Jul 2026

Oil & Gas

The Premarket Brief: MedPal AI raises £5m for care-home software and oral Wegovy clinic, Helix Exploration, Harbour Energy, Craneware, Ilika

07:51, 3 Jul 2026

Biotech

PureTech spins out Celea Therapeutics with $180m Raise

11:32, 2 Jul 2026

Real Estate & REITs

Supermarket Income REIT completes £445m debt refinancing at lower margin

08:34, 2 Jul 2026

Helical plc is a UK-listed pharmaceutical and biotechnology company focused on the development and commercialization of therapeutic solutions. The company operates primarily in the United Kingdom and European markets, positioning itself within the mid-cap segment of the biotech sector. As a development-stage biotech firm, Helical is characterized by R&D-driven operations with a pipeline of proprietary drug candidates in various stages of clinical development.

Sector: Pharma
Market: MAINMARKET

Insight

What occupancy level did Helical plc report at The Bower after the June 2026 regears and letting?

Helical plc reported occupancies at The Bower rising above 93% following the June 2026 regears and letting.

Updated 10 Jun 2026

Insight

What strategic targets or milestones has Helical plc disclosed in the Catalysts section?

The Catalysts section does not disclose any explicit medium-term targets, capital allocation plans, development milestones, or stated KPIs for Helical plc, and it includes no dated initiatives or strategic transactions.

Updated 10 Jun 2026

Insight

Do the provided sources include Helical plc's board composition or committee structures?

No. The provided sources do not include further board composition or committee structure details for Helical plc.

Updated 10 Jun 2026

Insight

What operational priorities does Helical plc emphasise for its London campus assets?

Helical plc prioritises active asset management and income‑certainty for its best‑in‑class London campus assets, focusing on driving occupancy, underwriting rents near ERVs, and extending lease tenor.

Updated 10 Jun 2026

Insight

What material about Helical plc is available in the section?

The section says the available material is limited to KG-cached metadata and a mention of a recent general news update.

Updated 10 Jun 2026

Identifiers

Ticker: HLCL
Market: MAINMARKET
ISIN: GB00B0FYMT95
LEI: 2138003SBD2Z7WV2MP70

Learn more on:

GLEIF Companies House

Timeline

Helical inks letting deal of Old Street property

Helical advances lettings and de‑risks pipeline ahead of full‑year results

More in Pharma

Hansoh Phase III win bolsters GSK's global case for Ris-Rez in lung cancer

Health & Bio Today: AstraZeneca ATTR-CM trial fails primary endpoint, Avacta, Spire Healthcare, Smith+Nephew

AstraZeneca and Ionis ATTR-CM trial fails primary endpoint

OKYO Pharma accelerates urcosimod into Phase 3 after FDA validates trial design

Physiomics wins contracts across two service lines

Segro doubles new rent secured in first half as development pipeline hits record

Coiled Therapeutics advances softgel formulation ahead of dose expansion

MedPal AI raises £5m to acquire care-home software firm and launch oral Wegovy clinic

The Premarket Brief: MedPal AI raises £5m for care-home software and oral Wegovy clinic, Helix Exploration, Harbour Energy, Craneware, Ilika

PureTech spins out Celea Therapeutics with $180m Raise

Supermarket Income REIT completes £445m debt refinancing at lower margin

Browse by Sector

Market reports

Energy & Resources

Financials

Technology

Healthcare

Industrials

Consumer